Ȩ > ´ÚÅÍÇÏÆ®¼Ò½Ä

 
¾È³çÇϽʴϱî? ´ÚÅÍÇÏÆ®¿¡¼­ °øÁö»çÇ×À» ¾Ë·Áµå¸³´Ï´Ù.
 
2024. 05. 01.
 Á¦12Â÷ ±¹Á¦ÀÌÁ¾À̽ÄÇÐȸ
±Û¾´ÀÌ: °ü¸®ÀÚ  ³¯Â¥: 2013.11.14. 11:32:57   Á¶È¸: 4244
2013³â 11¿ù 10ÀÏ~13ÀϱîÁö ÀϺ» ¿À»çÄ«, ¿À»çÄ«±¹Á¦È¸ÀÇÀå¿¡¼­ Á¦12Â÷ ±¹Á¦ÀÌÁ¾À̽ÄÇÐȸ Çмú´ëȸ°¡ ¼ºÈ²¸® °³ÃֵǾú´Ù.
Âü°¡ÀÚµéÀº Àü¼¼°è¸¦ Æ÷ÇÔÇÏ¿© ¹Ì±¹, À¯·´, È£ÁÖ, ´ºÁú¶õµå, Áß±¹, ÀϺ», Çѱ¹µî¿¡¼­ ¾à 400 ¿©¸íÀÇ ÀÌÁ¾À̽Ŀ¬±¸ °ü·ÃÇÐÀÚµéÀÌ 4ÀÏ°£ 400 ¿©ÆíÀÇ ÀÌÁ¾À̽İü·Ã ¿¬±¸¹ßÇ¥¿Í Ư°­, ½ÉÆ÷Áö¿òµîÀ¸·Î ¿­¶í Çмú´ëȸ°¡ ÁøÇàµÇ¾ú´Ù.
Çѱ¹¿¡¼­µµ ¿©·¯´ëÇп¡¼­ ¸¹Àº ¿¬±¸ÁøÀÌ Âü¼®ÇÏ¿´À¸¸ç ÃÊû°­¿¬, ¿¬±¸¹ßÇ¥¸¦ ½ÃÇàÇÏ¿´´Ù. ƯÈ÷ ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¿¬±¸ÁøÀÌ Çѱ¹ ´ëÇ¥µéÀÇ ÁÖ·ù¸¦ ÀÌ·ç°í ÃÊû°­ÀÇ, ÁÂÀå, ½Ê¿©ÆíÀÇ ¿¬±¸°á°ú¸¦ ¹ßÇ¥ÇÏ¿´´Ù. ¼­¿ï´ëÇб³º´¿ø ÈäºÎ¿Ü°ú¿¡¼­µµ  Development of novel combined anticalcification protocol including immunologic modification for prolonged durability of cardiac xenograft in animal study¿Í In-vivo efficacy for treatment with decellularization, alpha-galactosidase, spacefiller, organic solvent and detoxifixation of GA-fixed cardiac xenograft using alpha-gal mouse implantation model À̶õ ¿¬Á¦¸¦ ¹ßÇ¥ÇÏ¿´´Ù. ±Ý³â¿¡´Â alpha-gal KO pig¿¡ genetic modification ÁøÇàÀÌ ´õ¿í ÇöÀúÇÏ°í, genetically induced disease(agenesis) model°³¹ß, chimerism ¹æ¹ýµµ ´«ºÎ½Ã°Ô ¹ßÀüµÇ¾ú´Ù. Çѱ¹µµ ÀÌ·¯ÇÑ ÀÌÁ¾À̽Ŀ¡¼­ À¯ÀüÀÚ Ã³¸® ±â¼úµéÀÌ »¡¸® Çâ»óµÇ±æ ±â¿øÇÑ´Ù.
LIST  MODIFY DELETE WRITE  





Àüü±Û ¸ñ·Ï 2024. 05. 01.  Àüü±Û: 211  ¹æ¹®¼ö: 1030219
101 ÀÌÁ¾Àå±â ÆǸ·-ÆǸ·µµ°ü ¿¬±¸ workshop °ü¸®ÀÚ2010.01.18.4323
100 Áß±¹ ÇϾ¾Æµ¿º´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2009.11.25.4310
99 2009³â ÀÌÁ¾Àå±â Advisory symposium °ü¸®ÀÚ2009.11.09.4324
98 Á¦ 19Â÷ ¾Æ½Ã¾Æ ÈäºÎ ½ÉÀåÇ÷°ü¿Ü°úÀÇ»çÇùȸ Çмú´ëȸ °ü¸®ÀÚ2009.10.28.4272
97 Á¦ 23Â÷ À¯·´ ÈäºÎ¿Ü°úÇÐȸ ( EACTS) Çмú´ëȸ °ü¸®ÀÚ2009.10.23.4140
96 ¿ìÁŰ½ºÅº ±¹Á¦ ½ÉÆ÷Áö¿ò °ü¸®ÀÚ2009.09.29.4316
95 5th China-Korea-Japan Pediatric Herat Forum °ü¸®ÀÚ2009.09.14.4304
94 Á¦ 12Â÷ Update in Pediatric Cardiac Surgery & Cardi °ü¸®ÀÚ2009.08.31.4262
93 2009 ³â Heart Valve Disease Forum °ü¸®ÀÚ2009.08.31.4341
92 Áß±¹ ±æ¸²¼º ¿¬±æ ¿¬º¯´ëÇÐ º¹Áöº´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2009.08.23.4252
RELOAD WRITE
 1 ¢¸ [11] 12 [13] [14] [15] [16] [17] [18] [19] [20]  ¢º 22